Literature DB >> 25006205

'Behind blue eyes'†: the association between eye colour and deep infiltrating endometriosis.

Paolo Vercellini1, Laura Buggio2, Edgardo Somigliana3, Dhouha Dridi2, Maria Antonietta Marchese2, Paola Viganò4.   

Abstract

STUDY QUESTION: Is the prevalence of blue eye colour higher in women with deep endometriosis? SUMMARY ANSWER: Blue eye colour is more common in women with deep endometriosis when compared with both women with ovarian endometriomas and women without a history of endometriosis. WHAT IS KNOWN ALREADY: Recent and intriguing evidence suggests that women with deep endometriosis may have particular phenotypic characteristics including a higher prevalence of a light-colour iris. Available epidemiological evidence is however weak. STUDY DESIGN, SIZE, DURATION: Case-control study performed in a large academic department specializing in the study and treatment of endometriosis. Individual iris colour was evaluated in daylight and categorized in three grades, namely blue-grey (blue), hazel-green (green) and brown. One observer assessed iris colour. In addition, the women themselves were invited to indicate the colour of their eyes according to the same classification system. Cases with discordant eye colour determinations between the observer and the woman were excluded from the final analysis. PARTICIPANTS MATERIALS, SETTINGS,
METHODS: Two hundred and twenty-three women with deep endometriosis (cases), 247 with ovarian endometriomas and 301 without a history of endometriosis were enrolled. MAIN RESULTS AND THE ROLE OF CHANCE: After exclusion of 52 discordant cases, the proportions of brown, blue and green eye colours were, respectively, 61, 30 and 9% in the deep endometriosis group, 74, 16 and 10% in the endometrioma group and 75, 15 and 10% in the non-endometriosis group. Women in the deep endometriosis group had a statistically significant excess of blue eyes and a reduced proportion of brown eyes compared with the two control groups (P = 0.002 and P < 0.001, respectively). The proportion of blue eyes was almost identical in the ovarian endometrioma group and the non-endometriosis group, and that of green eyes was substantially similar in all study groups. The OR (95% CI) of having blue eyes in women with deep endometriosis compared with women with ovarian endometriosis and with those without endometriosis was, respectively, 2.2 (1.4-3.6) and 2.5 (1.6-3.9). LIMITATIONS, REASON FOR CAUTION: We cannot exclude that some women without a previous diagnosis of endometriosis indeed had the disease. However, this would have led to a reduction of the observed difference in proportion of blue eyes, thus to a potential underestimation of the real strength of the association. Moreover, under-ascertainment is possible with regard to peritoneal disease, but unlikely with deep endometriotic lesions and ovarian endometriomas. WIDER IMPLICATIONS OF THE
FINDINGS: There are two possible explanations for our findings. Both may have intriguing implications for future research on endometriosis. Firstly, genes involved in the control of iris colour transmission may lie in a region with a strong pattern of linkage disequilibrium with genes involved in the invasiveness of endometriosis. Alternatively, blue eye colour could be considered an indicator of a photo-sensitive phenotype resulting in limited exposure to sunlight and UVB radiation. Limited sunlight exposure is associated with reduced circulating 25-hydroxyvitamin D3, an element that has recently been linked to endometriosis development.
© The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  deep endometriosis; endometriosis; eye colour; ovarian endometrioma; vitamin D

Mesh:

Year:  2014        PMID: 25006205     DOI: 10.1093/humrep/deu169

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

Review 1.  IRIS COLOUR CLASSIFICATION SCALES--THEN AND NOW.

Authors:  Mariana Grigore; Alina Avram
Journal:  Rom J Ophthalmol       Date:  2015 Jan-Mar

2.  Recreational and residential sun exposure and risk of endometriosis: a prospective cohort study.

Authors:  Leslie V Farland; William J Degnan; Holly R Harris; Jiali Han; Eunyoung Cho; Trang VoPham; Marina Kvaskoff; Stacey A Missmer
Journal:  Hum Reprod       Date:  2021-01-01       Impact factor: 6.918

3.  Endometriosis and the risk of skin cancer: a prospective cohort study.

Authors:  Leslie V Farland; Simon Lorrain; Stacey A Missmer; Laureen Dartois; Iris Cervenka; Isabelle Savoye; Sylvie Mesrine; Marie-Christine Boutron-Ruault; Marina Kvaskoff
Journal:  Cancer Causes Control       Date:  2017-08-10       Impact factor: 2.506

4.  Long-term Health Consequences of Endometriosis - Pathways and Mediation by Treatment.

Authors:  Leslie V Farland; Holly R Harris
Journal:  Curr Obstet Gynecol Rep       Date:  2020-05-29

Review 5.  Clinical diagnosis of pelvic endometriosis: a scoping review.

Authors:  Hedyeh Riazi; Najmeh Tehranian; Saeideh Ziaei; Easa Mohammadi; Ebrahim Hajizadeh; Ali Montazeri
Journal:  BMC Womens Health       Date:  2015-05-08       Impact factor: 2.809

Review 6.  Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases.

Authors:  Juan J Tarín; Miguel A García-Pérez; Toshio Hamatani; Antonio Cano
Journal:  Reprod Biol Endocrinol       Date:  2015-04-15       Impact factor: 5.211

7.  Endometrial microbiota is more diverse in people with endometriosis than symptomatic controls.

Authors:  Jocelyn M Wessels; Miguel A Domínguez; Nicholas A Leyland; Sanjay K Agarwal; Warren G Foster
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

8.  Case-control study to develop and validate a questionnaire for the secondary prevention of endometriosis.

Authors:  Giuseppe Ricci; Elena Castelpietra; Federico Romano; Giovanni Di Lorenzo; Gabriella Zito; Luca Ronfani; Stefania Biffi; Lorenzo Monasta
Journal:  PLoS One       Date:  2020-03-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.